Answer
Elotuzumab targets signaling lymphocyte activation molecule family member 7 (SLAMF7), a protein highly expressed on multiple myeloma cells independent of cytogenetic abnormalities.
Sources for this answer
- Empliciti 300 mg and 400 mg powder for concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 12Document updated
Sources checked